Format

Send to

Choose Destination
J Clin Microbiol. 2016 Sep;54(9):2298-305. doi: 10.1128/JCM.00670-16. Epub 2016 Jun 22.

Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.

Author information

1
Mycobacteriology and Pharmacokinetics Laboratories, National Jewish Health, Denver, Colorado, USA National Reference Laboratory and Centre of Excellence (WHO), Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
2
Department of Academic Affairs, National Jewish Health, Denver, Colorado, USA Department of Pediatrics, National Jewish Health, Denver, Colorado, USA.
3
Mycobacteriology and Pharmacokinetics Laboratories, National Jewish Health, Denver, Colorado, USA.
4
Center for Genes, Environment, and Health, National Jewish Health, Denver, Colorado, USA.
5
National Reference Laboratory and Centre of Excellence (WHO), Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
6
Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
7
National Reference Laboratory and Centre of Excellence (WHO), Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India tbmicro@gmail.com salfingerm@njhealth.org.
8
Center for Genes, Environment, and Health, National Jewish Health, Denver, Colorado, USA Computational Bioscience Program, University of Colorado, Denver, Colorado, USA.
9
Mycobacteriology and Pharmacokinetics Laboratories, National Jewish Health, Denver, Colorado, USA Department of Medicine, National Jewish Health, Denver, Colorado, USA tbmicro@gmail.com salfingerm@njhealth.org.

Abstract

Fluoroquinolones (FQs) are broad-spectrum antibiotics recommended for the treatment of multidrug-resistant tuberculosis (MDR-TB) patients. FQ resistance, caused by mutations in the gyrA and gyrB genes of Mycobacterium tuberculosis, is increasingly reported worldwide; however, information on mutations occurring in strains from the Indian subcontinent is scarce. Hence, in this study, we aimed to characterize mutations in the gyrA and gyrB genes of acid-fast bacillus (AFB) smear-positive sediments or of M. tuberculosis isolates from AFB smear-negative samples from patients in India suspected of having MDR-TB. A total of 152 samples from patients suspected of having MDR-TB were included in the study. One hundred forty-six strains detected in these samples were characterized by sequencing of the gyrA and gyrB genes. The extracted DNA was subjected to successive amplifications using a nested PCR protocol, followed by sequencing. A total of 27 mutations were observed in the gyrA genes of 25 strains, while no mutations were observed in the gyrB genes. The most common mutations occurred at amino acid position 94 (13/27 [48.1%]); of these, the D94G mutation was the most prevalent. The gyrA mutations were significantly associated with patients with rifampin (RIF)-resistant TB. Heterozygosity was seen in 4/27 (14.8%) mutations, suggesting the occurrence of mixed populations with different antimicrobial susceptibilities. A high rate of FQ-resistant mutations (17.1%) was obtained among the isolates of TB patients suspected of having MDR-TB. These observations emphasize the need for accurate and rapid molecular tests for the detection of FQ-resistant mutations at the time of MDR-TB diagnosis.

PMID:
27335153
PMCID:
PMC5005506
[Available on 2017-03-01]
DOI:
10.1128/JCM.00670-16
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center